Crossmark

Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma

Crossref DOI link: https://doi.org/10.1007/s00262-025-04029-9

Published Online: 2025-04-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Berclaz, Luc M.

Burkhard-Meier, Anton

Lechner, Axel

Völkl, Michael

Güler, Sinan E.

Abdel-Rahman, Sultan

Mansoorian, Sina

Kunz, Wolfgang G.

Knösel, Thomas

Canis, Martin

von Bergwelt-Baildon, Michael

Issels, Rolf D.

Di Gioia, Dorit

Lindner, Lars H.
Funding

Funding for this research was provided by:

Klinikum der Universität München
License Information

Text and Data Mining valid from 2025-04-17

Version of Record valid from 2025-04-17
More Information

Article History

Received: 16 December 2024

Accepted: 19 March 2025

First Online: 17 April 2025

Declarations

:

: All authors declare no relevant conflicts of interest regarding this publication.The authors declare no competing interests.

: The Internal Review Board and the Ethical Review Committee at the Ludwig-Maximilians University (LMU) Hospital, Munich, Germany, approved the protocol of this research project (Protocol Nr. 24–0981).

: All authors have read and agreed to the published version of the manuscript.

Document is current

Any future updates will be listed below